Samanta Cimitan Appointed Chief Executive Officer (CEO) at Celonic
Advertisement
Celonic Group has appointed Dr. Samanta Cimitan as the Chief Executive Officer (CEO) of the Celonic Group, a subsidiary of the independent and privately owned J.RETTENMAIER & Söhne Company (JRS Group).
Samanta succeeds Dr. Konstantin Matentzoglu, who will step down after 9 years as CEO. During his tenure, Konstantin successfully repositioned the Celonic brand as a premium CDMO, delivered significant growth, and facilitated corporate development and strategic alliances. Konstantin Matentzoglu intends to remain a Member of the Celonic Board and will support Samanta during the transition.
With more than 20 years of experience working, teaching, and studying Life Sciences, Samanta is an expert in the CDMO industry, holding a deep and unique combination of scientific, commercial, and operational know-how.
Samanta joined Celonic in June 2022 as Chief Business Officer (CBO). During this time, she quickly articulated a new strategic direction for the Celonic business, solidified customer relationships, and accelerated innovation.
Prior to Celonic, Samanta was with Lonza for almost 13 years, holding several leadership positions across multiple commercial and strategy roles, including Vice President of Lonza Group Operations Strategy, developing and leading transformational programs across R&D, Operations and Commercial functions. Samanta holds a Ph.D. in Pharmaceutical Sciences from the University of Bologna, Italy, along with a master’s degree in Industrial Chemistry.
Most read news
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

BioGaia appoints Theresa Agnew as new CEO

EVIDENT Corporation Appoints New CEO and COO

Danaher appoints Christopher Riley to Executive Vice President for Biotechnology

Biotage AB appointment of new CEO

Dr. Christine Munz becomes CEO at Eppendorf - Dr. Wilhelm Plüster completes term in office as planned

Jung Foundation honours cutting-edge research: 4 prizes for medical breakthroughs - Their research has the potential to decisively transform the medicine of tomorrow, or has already done so

Leadership change at Köttermann B.V. in the Netherlands

1.2 million US dollar award honors pioneering work in cryo-electron tomography - Wolfgang Baumeister receives prestigious Shaw Prize

Leon-nanodrugs appoints Dr. Wolfgang Hofmann as Chief Executive Officer

Refeyn Announces Leadership Transition - Jonathan Flint Steps Down as Chairman, Jean-Paul Mangeolle Appointed as Successor

Joachim Kreuzburg, Former CEO of Sartorius, Joins Cube Biotech’s Board of Directors
